Bevacizumab in Mesothelioma
The overall survival benefit seen with addition of bevacizumab to cisplatin/pemetrexed in patients with mesothelioma is practice-changing, according to Naiyer Rizvi, MD. The panelists discuss the data presented at ASCO 2015.
source
Comments
Post a Comment